FDA approved IMBRUVICA (ibrutinib) plus Rituximab for ttreatment of patients with CLL
On Apr. 21, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced U.S. Food and Drug Administration…
VA researchers announced study of COVID-19 in aging Veterans with dementia
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…
Hydroxychloroquine study reported no benefit from malaria drug in Veteran Affairs virus study
On Apr. 21, 2020, a study posted on medRxiv found no evidence that use of hydroxychloroquine, either with…
More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
Todos Medical announced FDA Emergency Use Authorization allowed for Gnomegen COVID-19 PCR test kits
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
Rice University COVID-19 research fund awarded first grants
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…
RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
Roche developed new serology test to detect COVID-19 antibodies
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
Biotechnology | Disease | Influenza | Therapeutics | Vaccine
Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the National Institutes of Health (NIH) announced nearly $290 million of new funding for…
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare consortium build and share COVID-19 biobank
On Apr. 16, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
A gut-to-brain circuit drives sugar preference and may explain sugar cravings
On Apr. 15, 2020, Howard Hughes Medical Institute (HHMI) investigators report the sensation of sweetness starts on the…
Fujifilm accelerated production of its influenza antiviral drug ‘Avigan tablet’ for COVID-19
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…